Outcome of COVID-19 patients treated with VV-ECMO in Tyrol during the pandemic

A Peer, F Perschinka, G Lehner, T Mayerhöfer… - Wiener klinische …, 2024 - Springer
Introduction A small percentage of patients infected with the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2) showed severe respiratory deterioration requiring …

Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients

R Giraud, D Legouis, B Assouline… - Physiological …, 2021 - Wiley Online Library
Introduction Current knowledge on the use of extracorporeal membrane oxygenation
(ECMO) in COVID‐19 remains limited to small series and registry data. In the present …

[HTML][HTML] The Long-Term Support of COVID-19 Patients With Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Analysis From the ECMO Center in …

C Wiest, A Philipp, D Lunz, JF Steinmann… - Deutsches Ärzteblatt …, 2023 - ncbi.nlm.nih.gov
The Long-Term Support of COVID-19 Patients With Veno-Venous Extracorporeal Membrane
Oxygenation - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Venovenous extracorporeal membrane oxygenation for COVID-19 associated severe respiratory failure: Case series from a Hungarian tertiary centre

É Zöllei, L Rudas, P Hankovszky, A Korsós… - …, 2024 - journals.sagepub.com
Introduction Venovenous extracorporeal membrane oxygenation (VV ECMO) is
recommended for the support of patients with severe COVID-19 associated severe …

Mortality rates of severe COVID-19-related respiratory failure with and without extracorporeal membrane oxygenation in the Middle Ruhr Region of Germany

A Aweimer, L Petschulat, B Jettkant, R Köditz… - Scientific Reports, 2023 - nature.com
The use of extracorporeal membrane oxygenation (ECMO) is discussed to improve patients'
outcome in severe COVID-19 with respiratory failure, but data on ECMO remains …

The use of venovenous extracorporeal membrane oxygenation in COVID-19 infection: One region's comprehensive experience

ZR Bergman, JK Wothe, FS Alwan, A Dunn… - Asaio …, 2021 - journals.lww.com
Severe acute respiratory distress syndrome (ARDS) unresponsive to conventional intensive
care unit (ICU) management is an accepted indication for venovenous extracorporeal …

Extracorporeal membrane oxygenation in COVID-19: Results of the Croatian Extracorporeal Membrane Oxygenation Referral Center

M Kutleša, M Santini, V Krajinović… - … journal of artificial …, 2023 - journals.sagepub.com
At the beginning of the COVID-19 pandemic, the role of extracorporeal membrane
oxygenation (ECMO) was uncertain and the outcomes of ECMO-treated patients were …

Variation in outcomes with extracorporeal membrane oxygenation in the era of coronavirus: A multicenter cohort evaluation

AH Stammers, EA Tesdahl, AK Sestokas… - …, 2023 - journals.sagepub.com
Extracorporeal membrane oxygenation (ECMO) is used in critically ill patients with
coronavirus disease 2019 (COVID-19) with acute respiratory distress syndrome …

Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19

B Kieninger, M Kilger, M Foltan, M Gruber, D Lunz… - PLoS …, 2023 - journals.plos.org
Background Patients with COVID-19 and severe acute respiratory failure may require veno-
venous extracorporeal membrane oxygenation (VV ECMO). Yet, this procedure is resource …

[HTML][HTML] Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): multicenter experience of referral …

E Shih, JM DiMaio, JJ Squiers, JK Banwait… - The Journal of Thoracic …, 2022 - Elsevier
Background The benefit of extracorporeal membrane oxygenation (ECMO) for patients with
severe acute respiratory distress from coronavirus disease 2019 refractory to medical …